Olink Holding AB (publ) at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 05:35PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

All right. Good afternoon, everyone. My name is Tejas Savant, I'm the life science tools and diagnostics analyst here at Morgan Stanley. Before we begin, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.

So it's my great pleasure this afternoon to host Olink. And from the company, we have Carl Raimond, President; and Oskar Hjelm, CFO. So thank you both for doing this.

Carl Raimond - Olink Holding AB(publ)-President

Thank you for having us.

Questions and Answers:

Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

Maybe, Carl, to set the stage, can you just discuss what you view as your key accomplishments over the past 6 to 12 months? And what do you view as the most important opportunities in those rolling heading into 2024?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot